ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0073

HLA-DQA1*01:02 Is Associated With IgG Multi-Reactivity With Citrulline-Containing Type II Collagen Epitopes While HLA-DRB*04:01 Is Associated With More Private Reactivity With Citrulline-Containing IgG Epitopes In Rheumatoid Arthritis

S. Janna Bashar1, Courtney Myhr1, Adam Titi1, Zihao Zheng1 and Miriam Shelef2, 1University of Wisconsin-Madison, Madison, 2University of Wisconsin-Madison, Madison, WI

Meeting: ACR Convergence 2025

Keywords: Anti-citrullinated Protein Autoantibodies (ACPAs), Autoantibody(ies), genetics, rheumatoid arthritis, Rheumatoid Factor

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0067–0097) Rheumatoid Arthritis – Etiology and Pathogenesis Poster

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Anti-citrullinated protein antibodies (ACPAs) in rheumatoid arthritis (RA) can be promiscuous, with cross-reactive binding to many antigens containing short motifs, or more private with little cross-reactivity. Also, ACPA reactivity patterns differ among people with RA, including for motif-containing epitopes in important self-antigens like type II collagen and IgG (the latter of which is bound by RA-associated rheumatoid factors, RFs), with limited understanding of the underlying mechanism. The objective of this study was to determine if HLA alleles associate with ACPA reactivity patterns.

Methods: For 100 ACPA+RF+ RA participants, serum IgG binding was quantified by enzyme-linked immunosorbent assay to five citrulline-containing peptides derived from type II collagen (all with citrulline-glycine motifs) and five citrulline-containing peptides derived from IgG1 (four with citrulline-serine motifs). Also, antibody and serum multi-reactivity were evaluated. HLA loci were genotyped, and HLA alleles present differentially in RA participants with high versus low IgG binding to specific peptides as well as with multi-reactivity versus limited reactivity were identified by Fisher’s exact test.

Results: Serum IgG multi-reactivity for citrulline-glycine motif-containing collagen peptides was high, at least partially due to promiscuous antibodies. HLA-DQA1*01:02 was present in more participants with anti-citrullinated collagen antibodies and sera multi-reactive with the collagen peptides. In contrast, serum multi-reactivity was low for IgG1-derived peptides due at least in part to more private antibodies. Shared epitope-containing HLA-DRB*04:01 and HLA-DRB*10:01 were present more frequently in participants with some RA-associated RFs that bind citrulline-containing IgG epitopes, irrespective of a citrulline-serine motif. Several HLA alleles associated with specific IgG reactivities.

Conclusion: These findings suggest that specific HLA alleles may contribute to the different reactivity patterns of promiscuous anti-citrullinated collagen antibodies and more private RA-associated RFs. Moreover, to the best of our knowledge, these findings provide the first evidence for a role for HLA-DQA1*01:02 in RA as well as the first HLA association with autoantibody multi-reactivity.


Disclosures: S. Bashar: None; C. Myhr: None; A. Titi: None; Z. Zheng: None; M. Shelef: Revel Pharmaceuticals, 2.

To cite this abstract in AMA style:

Bashar S, Myhr C, Titi A, Zheng Z, Shelef M. HLA-DQA1*01:02 Is Associated With IgG Multi-Reactivity With Citrulline-Containing Type II Collagen Epitopes While HLA-DRB*04:01 Is Associated With More Private Reactivity With Citrulline-Containing IgG Epitopes In Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/hla-dqa10102-is-associated-with-igg-multi-reactivity-with-citrulline-containing-type-ii-collagen-epitopes-while-hla-drb0401-is-associated-with-more-private-reactivity-with-citrulline-containing-ig/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hla-dqa10102-is-associated-with-igg-multi-reactivity-with-citrulline-containing-type-ii-collagen-epitopes-while-hla-drb0401-is-associated-with-more-private-reactivity-with-citrulline-containing-ig/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology